Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

960 results about "Liver damage" patented technology

Liver disease can be inherited (genetic) or caused by a variety of factors that damage the liver, such as viruses and alcohol use. Obesity is also associated with liver damage. Over time, damage to the liver results in scarring (cirrhosis), which can lead to liver failure, a life-threatening condition.

Treatment of migraine

ActiveUS20250009722A1Organic active ingredientsNervous disorderHepatic impairmentDepressant
The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and / or P-gp only inhibitors.
Owner:MERCK SHARP & DOHME LLC

Treatment of migraine

ActiveUS12168004B2Organic active ingredientsNervous disorderHepatic impairmentDepressant
The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and / or P-gp only inhibitors.
Owner:MERCK SHARP & DOHME LLC

Treatment of migraine

ActiveUS12220408B2Organic active ingredientsNervous disorderHepatic impairmentDepressant
The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and / or P-gp only inhibitors.
Owner:MERCK SHARP & DOHME LLC

Treatment of migraine

ActiveUS12194030B2Organic active ingredientsNervous disorderHepatic impairmentDepressant
The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and / or P-gp only inhibitors.
Owner:ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD

Treatment of migraine

InactiveUS20250064788A1Organic active ingredientsNervous disorderHepatic impairmentDepressant
The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and / or P-gp only inhibitors.
Owner:MERCK SHARP & DOHME LLC

Traditional Chinese medicine composition and its application in preparing products for preventing, alleviating or treating acute hepatopancreatic necrosis of shrimp

The invention provides a traditional Chinese medicine composition and an application thereof in preparing a product for preventing, alleviating or treating acute hepatopancreatic necrosis of shrimp, belonging to the field of veterinary medicine. The active ingredients of the traditional Chinese medicine composition include isatis root, artificial bezoar, liquorice, borneol, pig gall powder and xuanming powder. The traditional Chinese medicine composition has a good therapeutic effect on preventing, alleviating or treating acute hepatopancreatic necrosis of shrimp, with a cure rate of more than 70%, has antibacterial and liver-protecting effects, can effectively improve the degree of liver damage, improve the survival rate of shrimp and reduce losses.
Owner:BEIJING CENT BIOLOGY CO LTD +1

Medicinal and edible composition, preparation method and application of medicinal and edible composition in relieving acute alcoholic liver injury

The invention relates to the technical field of medicines, in particular to a medicinal and edible composition, a preparation method and application of the medicinal and edible composition in relieving acute alcoholic liver injury, and provides the medicinal and edible composition which is composed of ginseng, poria cocos, radix puerariae, fructus lycii, fructus gardeniae, fructus mume and oligo-walnut peptide. The medicinal and edible composition disclosed by the invention is non-toxic, harmless and high in nutritional value, and does not cause severe stimulation and harm to an organism. The health-care wine has a good effect of relieving liver injury, and is especially suitable for people with weakness due to long-term excessive drinking. Meanwhile, animal experiments and clinical verifications prove that the medicinal and edible composition for relieving acute alcoholic liver injury provided by the invention can effectively relieve liver functions, is one of effective methods for relieving symptoms after drinking, relieving inflammation, protecting the liver and improving the life quality, and has a wide application prospect. And a medicinal and edible combination product with good safety and good liver protection effect can be provided clinically. The important social significance is realized on relieving liver inflammation and preventing and treating occurrence and development of liver diseases.
Owner:YUNNAN UNIVERSITY OF CHINESE MEDICINE +1

Construction method and application of genetically modified mesenchymal stem cells

The invention discloses a construction method and application of a gene modified mesenchymal stem cell. The construction method comprises the following steps: constructing a recombinant lentivirus carrying PD-L1 and ICAM1 genes; the recombinant lentivirus carrying the PD-L1 gene and the ICAM1 gene is transfected with mesenchymal stem cells, and the mesenchymal stem cells are screened by puromycin, so that an engineered mesenchymal stem cell strain modified by the PD-L1 gene and the ICAM1 gene is obtained; the mesenchymal stem cells provided by the invention are modified by engineering genes of PD-L1 and ICAM1, and are screened by puromycin to obtain a mesenchymal stem cell strain capable of stably and highly expressing the genes of PD-L1 and ICAM1; after the mesenchymal stem cells highly expressing the PD-L1 and ICAM1 genes are intravenously injected into an autoimmune hepatitis animal model, the autoimmune hepatitis symptom can be remarkably relieved, the liver injury degree can be reduced, the expression of inflammatory factors can be regulated, the inflammatory reaction can be inhibited, and the obvious curative effect can be achieved.
Owner:XIAN CHAOYUE STEM CELL TECH CO LTD

L-β-galactoglucan produced from agrobacterium, preparation method for l-β-galactoglucan, and use of l-β-galactoglucan

The present invention provides L-β-galactoglucan, a preparation method therefor, and a use thereof. The polysaccharide is sinistrin, is composed of β-D-glucose and β-D-galactose, and has a molecular weight of not less than 5000 Da. The preparation method for the polysaccharide comprises: inoculating Agrobacterium FN01 in a culture solution for fermentation to obtain a fermentation broth; mixing the fermentation broth with alcohol, and carrying out precipitation and drying to obtain a crude polysaccharide product; and then carrying out purification to obtain a purified polysaccharide product, or carrying out enzymolysis on the fermentation broth by using glucanase, and then carrying out filtration, ultrafiltration concentration, and spray-drying to obtain a purified polysaccharide product. The polysaccharide has the effects of treating and / or preventing liver injury, resisting aging, decreasing blood sugar, repairing tissues and the like, and is a multipurpose polysaccharide.
Owner:CHENGDU SYDIX BIOTECH CO LTD

Treatment of migraine

ActiveUS20250177365A1Organic active ingredientsNervous disorderHepatic impairmentDepressant
The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and / or P-gp only inhibitors.
Owner:MERCK SHARP & DOHME LLC

Application of pediococcus acidilactici ZJUIDS13 in improvement of liver diseases

The invention relates to the technical field of microorganisms, in particular to application of pediococcus acidilactici ZJUIDS13 in improvement of liver diseases, including improvement of alcoholic liver diseases and improvement of fatty liver diseases related to metabolic dysfunction. The pediococcus acidilactici ZJUIDS13 has relatively strong capability of protecting liver injury induced by alcohol, and can improve the states of liver injury and lipid metabolism disorder caused by high fat diet.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

Method of treating depression using seltorexant

PCT designated stage expiredWO2025003991A1Organic active ingredientsNervous disorderHepatic impairmentReduced dose
A method of treating an orexin-2 mediated disorder in a human subject in need thereof is provided. The method comprises administering seltorexant or a pharmaceutically acceptable salt or hydrate thereof at a therapeutically effective daily dose to the subject, when the subject does not have a hepatic impairment. The method also comprises administering seltorexant or the pharmaceutically acceptable salt or hydrate thereof at a reduced dose less than the daily dose to the subject, when the subject has moderate hepatic impairment.
Owner:JANSSEN PHARMA NV

Hepatitis patient full-cycle management method based on block chain

The invention relates to the technical field of hepatitis diagnosis and treatment management, and discloses a block chain-based hepatitis patient full-period management method. The method comprises the following steps: creating a patient identity chain in a block chain network, and storing patient registration data and initial diagnosis information; full-cycle diagnosis and treatment data of a patient are obtained and divided into clinical examination, iconography, medication records and life sign monitoring data. Performing multi-dimensional cleaning on the clinical examination data to generate a standardized data set; inputting the iconography data into a pre-trained hepatitis feature extraction model, and outputting a liver injury feature set; verifying the integrity of the medication record, and generating a non-tampering medication time sequence chain; comparing the life sign monitoring data with preset health reference parameters to generate a sign deviation coefficient set; according to the method, data safety and traceability are guaranteed through the block chain, diagnosis and treatment data quality is improved through multi-dimensional data processing, patient privacy is protected, and reliable support is provided for full-period management of hepatitis patients.
Owner:AFFILIATED HOSPITAL OF SHAOXING UNIV OF ARTS & SCI

Composition for dispelling effects of alcohol and protecting liver and application thereof

The invention relates to the field of food and health care products, and discloses a composition for dispelling effects of alcohol and protecting liver, which comprises 20-100 parts of ampelopsis grossedentata leaf extract; 50 to 200 parts of a radix puerariae extract; 10-50 parts of a semen hoveniae extract; 10-50 parts of a turmeric extract; 10 to 100 parts of a yeast extract; 5-50 parts of a licorice extract; and 5 to 20 parts of pyrroloquinoline quinone disodium salt. The ampelopsis grossedentata leaf extract, the kudzuvine root extract and the hovenia dulcis thunb extract are utilized, alcohol decomposition is promoted, the blood ethanol concentration is reduced, and drunkenness symptoms are relieved. Puerarin improves activity of liver metabolic enzymes, accelerates discharge of ethanol and acetaldehyde, and reduces liver damage. The anti-oxidation effects of dihydromyricetin and PQQ can eliminate alcohol metabolism free radicals and protect liver cells. The components such as puerarin, hovenia dulcis thunb, curcumin and glycyrrhizic acid jointly promote liver cell regeneration, inflammation and oxidative damage are reduced, the levels of ALT and AST in serum are reduced, and liver health is maintained.
Owner:EUGENE EXCELLENCE (TIANJIN) BIOMEDICAL TECH CO LTD

Treatment of migraine

ActiveUS12458632B2Organic active ingredientsNervous disorderHepatic impairmentDepressant
The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and / or P-gp only inhibitors.
Owner:MERCK SHARP & DOHME LLC

Edible and medicinal composition for dispelling effects of alcohol and protecting liver as well as preparation method and application of edible and medicinal composition

The invention discloses an edible and medicinal composition for dispelling effects of alcohol and protecting liver as well as a preparation method and application thereof, and belongs to the technical field of functional foods. The composition consists of the following raw materials in parts by weight: 1-8 parts of ampelopsis grossedentata extract freeze-dried powder, 1-8 parts of astragalus membranaceus extract freeze-dried powder, 1-5 parts of kudzu vine root extract freeze-dried powder, 1-8 parts of hawthorn extract freeze-dried powder and 1-5 parts of cassia seed extract freeze-dried powder. The composition is designed according to a multi-component synergistic interaction principle, and the functions of protecting the liver and dispelling the effects of alcohol are enhanced through targeted interaction of active ingredients such as ampelopsis grossedentata flavone, puerarin and astragaloside; the compound preparation has the compound effects of protecting the liver, dispelling the effects of alcohol, resolving dampness, resisting oxidative stress, regulating lipid metabolism and the like, can remarkably relieve the problems of acute and chronic liver injury and metabolic disorder caused by alcohol intake, and meets the food-grade safety standard and the medicinal activity requirement; the important application prospect is realized in the aspect of preparing a preparation for relieving alcoholic liver injury and improving the liver detoxification function.
Owner:NANJING JIANKE TONGCHUANG BIOTECHNOLOGY CO LTD +1

Strain of Witzia ciliaris with fat-reducing and weight-reducing functions

The invention discloses a strain of Witzia ciliaris with fat-reducing and weight-reducing functions, and belongs to the technical field of microorganisms. On the basis of reducing blood fat and weight, the screened Witzia ciliaris can inhibit the content and activity of fat synthase and relieve liver injury caused by high-fat diet, also has excellent acid resistance, bile salt resistance and efficient fat hydrolysis ability, is a strain of multifunctional Witzia ciliaris, and has good application prospects. The method has a wide application prospect in preparation of lipid-lowering, weight-losing and weight-losing products.
Owner:JIANGGONG MICROBREW (WUXI) BIOTECHNOLOGY CO LTD +1

Human umbilical cord mesenchymal stem cell injection and preparation method thereof

The invention relates to the technical field of stem cell injections, in particular to a human umbilical cord mesenchymal stem cell injection and a preparation method thereof. The cell cryoprotectant comprises the following components: a cell cryoprotectant and P6-generation human umbilical cord mesenchymal stem cells. By selecting P6-generation human umbilical cord mesenchymal stem cells, the capacity of secreting hepatocyte growth factors (HGF) can be improved; the cell cryoprotectant contains 6-9wt% of dimethyl sulfoxide and a certain amount of human serum albumin, can better protect cells and maintain the motility rate and biological functions of the cells, and is more beneficial to preparation of cryopreserved human umbilical cord mesenchymal stem cell injection. The P6-generation human umbilical cord mesenchymal stem cells are obtained by culturing a culture medium containing fetal calf serum, and the ability of the injection to repair liver injury can be improved.
Owner:QIANSHI BIOTECHNOLOGY (SHANGHAI) CO LTD

Active peptide with effects of resisting oxidation and protecting alcoholic liver injury and application of active peptide

The invention discloses an active peptide with effects of resisting oxidation and protecting alcoholic liver injury and application of the active peptide. According to the invention, walnut protein hydrolysate is taken as a raw material, and two novel peptide fragments HGEPGQQQR and VAPFPEVFGK with high antioxidant activity are obtained through screening. The two active peptides show good antioxidant activity on the cellular level, and the EC50 values of the two active peptides are 0.0120 mg / mL and 0.0068 mg / mL respectively, which are both superior to 0.0122 mg / mL of positive control glutathione. In an ethanol injury model, the survival rates of cells subjected to ethanol injury treatment can be respectively increased from 47.35% to 62.69% and 57.05% by the two antioxidant peptides. The results show that the walnut protein source antioxidant peptides HGEPGQQQR and VAPFPEVFGK can be developed and applied as a potential antioxidant and a liver protection active component.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Lipid emulsion for parenteral nutrition comprising GPC

The present disclosure relates to parenteral nutritional formulations, including ready-to-use parenteral nutrition formulations. More particularly, the present disclosure is directed to lipid formulations or emulsions and multi-chamber containers comprising same, wherein the lipid emulsion contains glycerophosphorylcholine as a choline source. The present disclosure further relates to methods of providing choline to a patient in need of parenteral nutrition and methods of avoiding and / or treating choline deficiency and liver damage.
Owner:BAXTER INT INC +1

Treatment of migraine

ActiveUS12458633B2Organic active ingredientsNervous disorderHepatic impairmentDepressant
The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and / or P-gp only inhibitors.
Owner:MERCK SHARP & DOHME LLC

Application of lactobacillus mucilaginosus strain A21196 in preparation of product for promoting ethanol metabolism

The invention provides application of a lactobacillus mucus fermentation strain A21196 in preparation of a product for promoting ethanol metabolism, and belongs to the technical field of microbial preparations. The lactobacillus mucus fermentation strain A21196 has the high-yield ethanol dehydrogenase and acetaldehyde dehydrogenase, and has the effects of reducing the content of ethanol and acetaldehyde in the blood of mice suffering from acute alcoholism and shortening the central nervous inhibition time in vivo. Therefore, the invention provides the application of the fermented lactobacillus mucus strain A21196 in preparation of a product for preventing and / or treating the alcoholic liver injury or the alcoholic liver disease.
Owner:AIAGE LIFE SCI CORP LTD

Lactobacillus paracasei grx06 and application of lactobacillus paracasei grx06 in aspects of dispelling effects of alcohol and protecting liver

The invention discloses a Lactobacillus paracasei grx06 and an application thereof in the aspects of dispelling the effects of alcohol and protecting the liver, the strain number of the Lactobacillus paracasei is grx06, the Lactobacillus paracasei is preserved in the China General Microbiological Culture Collection Center on February 18, 2025, and the preservation number is CGMCC No: 33560. The lactobacillus paracasei obtained by screening in the invention has the capability of producing ethanol dehydrogenase and acetaldehyde dehydrogenase at high yield, and is high in ethanol tolerance. In addition, the traditional Chinese medicine composition has the effects of promoting ethanol metabolism in rats and recovering liver injury. Wide application prospects are realized in the field of anti-alcohol and liver-protecting products.
Owner:YANGZHOU UNIV

Microacidophilic oligotrophic monocytogenes capable of improving metabolic liver disease and its application

The present invention discloses Stenotrophomonas acidaminiphila and its application for improving metabolic liver disease, and belongs to the field of microbial technology. The deposit number of the above-mentioned Stenotrophomonas acidaminiphila is CGMCC No.26919. It has been verified through experiments that the bacteria have an inhibitory effect on the increase of plasma ALT and AST caused by alcohol; it has an inhibitory effect on the increase of MDA, and restores the activity of liver GSH and SOD; it has an inhibitory effect on the increase of inflammatory factors in liver cells; it reduces liver fat vesicles and reduces inflammatory cell infiltration. Therefore, the bacteria can effectively alleviate liver damage caused by alcohol. In addition, the bacteria can also effectively alleviate the symptoms of non-alcoholic fatty liver disease caused by high fat. Therefore, the present invention has important clinical significance for the relief and treatment of metabolic-related fatty liver disease including alcoholic liver disease and non-alcoholic fatty liver disease.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

Bifidobacterium animalis subsp. Lactis BA-C9 capable of improving diabetes and application thereof

The invention discloses animal bifidobacterium subsp. Lactis BA-C9 capable of improving diabetes and application of the animal bifidobacterium subsp. Lactis BA-C9, the animal bifidobacterium subsp. Lactis BA-C9 is preserved in China Center for Type Culture Collection on March 11, 2024, and the preservation number is CCTCC NO: M2024457. The product prepared from the animal bifidobacterium subsp. Lactis BA-C9 has the beneficial effect of improving diabetes mellitus, can reduce fasting blood-glucose and liver injury, and has the capabilities of improving insulin resistance, glucose tolerance and dyslipidemia.
Owner:ZHONGCHUANG YIKE (SHANGHAI) BIOTECHNOLOGY CO LTD

Application of plant starch in preparation of product for dispelling effects of alcohol and protecting liver

The invention discloses an application of plant starch in preparation of a product for dispelling effects of alcohol and protecting liver. The golden sweet potato starch can be effectively used for dispelling the effects of alcohol and protecting the liver for the first time, the activity of key enzymes ADH and ALDH in an ethanol metabolism path is enhanced, the in-vivo ethanol metabolism speed is increased, liver damage caused by drunkenness is relieved, the golden sweet potato starch has the body protection effect, meanwhile, the drunkenness rate can be reduced, the drunkenness time can be shortened, the content of ALT, AST, TC, TG and LDL-C in the body can be remarkably reduced, and the anti-alcohol effect is achieved. According to the invention, the content of HDL-C is increased, the activity of CAT, SOD and GSH in the liver of the organism is remarkably improved, the MDA level of the liver is reduced, the fat accumulation condition of the liver of the organism is remarkably improved, and a new direction is provided for preparation of products for dispelling the effects of alcohol and protecting the liver.
Owner:EZHOU YUYUAN TECH CO LTD

Preparation method of composition for dispelling effects of alcohol and protecting liver

The invention discloses a preparation method of a composition for dispelling effects of alcohol and protecting liver, and belongs to the technical field of traditional Chinese medicines. The liver protection composition is prepared from the following raw materials: gynostemma pentaphyllum powder, honeysuckle flower powder, hawthorn fruit powder, green tea powder, lotus leaf powder, cassia seed powder and folium sennae powder. The preparation method of the liver protection composition comprises the following steps: enzymolysis, fermentation and freeze-drying. According to the invention, through an extraction method of firstly performing enzymolysis and then performing fermentation, various different types of active effective components are reserved as far as possible. Tests prove that the finally obtained composition has a statistical therapeutic effect on alcoholic liver injury.
Owner:BEIJING AOTE SHUER HEALTH PROD DEV

Weizmannia coagulans with fat-reducing and weight-reducing functions

The application discloses a Weizmannia coagulans with fat-reducing and weight-reducing functions, and belongs to the technical field of microorganisms. The Weizmannia coagulans screened by the application can inhibit the content and activity of fat synthesis enzyme on the basis of reducing blood fat and weight, can relieve liver damage caused by high-fat diet, has excellent acid tolerance, bile salt tolerance and high fat hydrolysis capacity, and is a multifunctional Weizmannia coagulans, and has a wide application prospect in the preparation of fat-reducing, weight-reducing and weight-losing products.
Owner:JIANGGONG MICROBREW (WUXI) BIOTECHNOLOGY CO LTD +1

Application of aromatic sulfonamide compound in preparation of medicine for preventing and treating liver injury

The invention provides application of an aromatic sulfonamide compound in preparation of a medicine for preventing and treating liver injury. The aromatic sulfonamide compound BC2059 provided by the invention can be used for inhibiting transcription and protein synthesis of related genes of Fibronectin and CollagenI in hepatic stellate cells, and plays a role in treating liver injury mice induced by bile duct ligation and carbon tetrachloride. The invention provides a potential drug molecule with a new action mechanism for treating liver injury.
Owner:ZHEJIANG UNIV +1

Traditional Chinese medicine preparation fermentation liquor, preparation method thereof and application of traditional Chinese medicine preparation fermentation liquor in aspects of losing weight, lowering lipid and / or relieving liver injury

The invention discloses fermentation liquor of a traditional Chinese medicine preparation, a preparation method of the fermentation liquor and application of the fermentation liquor in the aspects of losing weight, lowering lipid and / or relieving liver injury. The traditional Chinese medicine preparation is prepared from the following components in parts by weight: 3 to 6 parts of mulberries, 3 to 6 parts of raspberries, 3 to 6 parts of fructus corni, 12 to 20 parts of fructus lycii, 15 to 25 parts of rhizoma polygonati, 15 to 25 parts of fructus crataegi and 2 to 5 parts of semen cassiae. The traditional Chinese medicine preparation is prepared by extracting, sterilizing, cooling, inoculating a leavening agent and fermenting. The mulberry, the raspberry and the dogwood which are medicinal and edible materials are used for replacing fleece-flower root, the original formula of the lipid-lowering drug is combined, the fermentation liquor prepared after fermentation can effectively retain the obesity adjusting effect of the classic formula of the lipid-lowering drug, meanwhile, the biological activity of the lipid-lowering drug is remarkably improved through the optimized compatibility and the probiotic fermentation technology, and the lipid-lowering drug has a good application prospect. A safe and efficient innovative scheme is provided for functional food to intervene in obesity / overweight.
Owner:YANGZHOU UNIV